Read More Pharma Industry News LEO Pharma secures global rights to JW1601 in $402m deal with JW Pharmaceutical LEO Pharma, a leading Danish pharmaceutical company, has acquired global exclusive rights to the atopic dermatitis drug JW1601… bypharmanewsdailyAugust 27, 2018